APA

Chen H., Cong X., Wu C., Wu X., Wang J., Mao K., Li J., Zhu G., Liu F., Meng X., Song J., Sun X., Wang X., Liu S., Zhang S., Yang X., Song Y., Yang Y. & Sun T. (20201119). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9. : Science advances.

Chicago

Chen Hongmei, Cong Xiuxiu, Wu Chenxi, Wu Xuan, Wang Jialiang, Mao Kuirong, Li Jie, Zhu Ge, Liu Feiqi, Meng Xiandi, Song Jia, Sun Xu, Wang Xin, Liu Shuhan, Zhang Shi, Yang Xianzhu, Song Yanqiu, Yang Yong-Guang and Sun Tianmeng. 20201119. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9. : Science advances.

Harvard

Chen H., Cong X., Wu C., Wu X., Wang J., Mao K., Li J., Zhu G., Liu F., Meng X., Song J., Sun X., Wang X., Liu S., Zhang S., Yang X., Song Y., Yang Y. and Sun T. (20201119). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9. : Science advances.

MLA

Chen Hongmei, Cong Xiuxiu, Wu Chenxi, Wu Xuan, Wang Jialiang, Mao Kuirong, Li Jie, Zhu Ge, Liu Feiqi, Meng Xiandi, Song Jia, Sun Xu, Wang Xin, Liu Shuhan, Zhang Shi, Yang Xianzhu, Song Yanqiu, Yang Yong-Guang and Sun Tianmeng. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9. : Science advances. 20201119.